Please Note: We Are Not Accepting AFFF or PFAS Cases
Fob & Foster Personal Injury Lawyers are not currently accepting new AFFF firefighting foam or PFAS personal injury claims. We have left this page up because the litigation and settlement information below is accurate and worth reading, but we are not able to review or take these cases.
If you or a loved one was exposed to AFFF and diagnosed with kidney, testicular, liver or thyroid cancer, ulcerative colitis or thyroid disease, please speak with a firm handling these claims soon. The deadlines in 3M’s November 2026 settlement and the court’s orders run regardless of who represents you, and waiting can end a claim before anyone evaluates it.
If you have a different injury claim in Alabama, Georgia, or Tennessee, we would be glad to hear from you. Call (205) 407-6009 or see the cases we do handle on our practice areas page.
Last Updated: November 6, 2026
AFFF Firefighting Foam Lawsuit in Washington DC — November 2026 Status
- The claim: firefighters, military service members, airport workers, and people with contaminated water exposure diagnosed with kidney cancer, testicular cancer, and other PFAS-linked conditions
- Where the cases are: MDL 2873 before Judge Richard Gergel in the District of South Carolina, 15,270 personal injury lawsuits pending as of November 2, 2026 per JPML figures
- The settlement: 3M agreed November 3, 2026 to pay $7.35 billion over nine years to resolve most personal injury claims; DuPont, Chemours and Corteva have not settled
- DC deadline: generally 3 years, but exposure and diagnosis timelines complicate it, so do not wait. Lawyers must identify clients eligible for the 3M settlement by November 13, 2026
Companies such as Dupont and 3M sold hazardous firefighting foams for many years, all the while knowing the risks they posed.
AFFF products can cause various diseases and cancers, including liver, kidney, pancreatic, prostate, and testicular.
Fob & Foster Personal Injury Lawyers currently represents approximately 850 people across the country in toxic exposure cases.
This guide explains the AFFF firefighting foam litigation for Washington, D.C. readers: what AFFF is, the cancers and conditions linked to PFAS exposure, which manufacturers are being sued, who qualifies, what the cases are worth, how the 3M settlement works and how long you have to file. Fob & Foster Personal Injury Lawyers are not accepting new AFFF cases; see the notice above.
What Is AFFF?
Aqueous Film-Forming Foam (AFFF) is a specialized foam substance used to extinguish petroleum- and jet fuel-based fires.
Made primarily by 3M and Dupont, AFFF (firefighting foam) has been used in America and abroad since at least the early 1970s by firefighters, military, and factory personnel.
The product helps form a protective blanket over fuel that smothers a fire when water alone cannot put it out.
What Is the Washington DC AFFF Lawsuit About?
AFFF is known to contain per- and polyfluoroalkyl substances (PFAS), a series of synthetic chemical compounds that have been linked to various cancers.
Unfortunately, PFAS chemicals can bind to proteins and accumulate in the bodies of exposed humans. The PFAS works its way into the blood stream of firefighters and others that use AFFF products.
Despite knowing the risks associated with PFAS, some companies manufactured and profited from toxic firefighting foam for decades.
In 2010, the EPA asked these companies to cease manufacturing and using certain PFAS. In response, some companies began using “short-chain” PFAS, which were supposed to be safer for humans. However, recent studies have indicated that’s not the case.
The bottom line is large corporations like 3M and DuPont manufactured and sold hazardous firefighting foams for many years, all the while knowing the foam can cause cancer.
What Cancers Are Linked To Firefighting Foam (AFFF) Products?
The known injuries caused by AFFF products are evolving. For now, the focus of the AFFF lawsuit is on the following injuries:
- Kidney cancer
- Thyroid disease – Hypo and Hyperthyroidism
- Ulcerative colitis
- Liver cancer
- Testicular cancer
- Thyroid cancer
Which Companies Manufactured Toxic AFFF Products?
The following companies manufactured firefighting foam that allegedly contained toxic PFAS chemicals:
- 3M
- Dupont
- AGC Chemicals Americas
- Arkema
- BASF Corporation
- Buckeye Fire Equipment Company
- ChemDesign Products, Inc.
- Chemours Company FC, LLC
- Chubb Fire, Ltd.
- Clariant
- Corteva
- Dynax Corporation
- Kiddle-Fenwal, Inc.
- Kidde P.L.C.
- National Foam, Inc.
- Tyco Fire Products, LP
- United Technologies
- UTC Fire and Security Americas Corporation, Inc.
Note that the AFFF product used by you could be the same product on the list but marketed under a different name.
Who Qualifies For the Firefighting Foam Lawsuit in D.C.?
A resident of DC who has been exposed to PFAS checmicals in AFFF and diagnosed with cancer may qualify for the AFFF lawsuit in Washtington D.C.
Your case generally qualifies for the AFFF lawsuit if it meets two criteria:
- You were exposed to PFAS over a long period of time. For example, if you used AFFF (firefighting foam) products throughout your job as a firefighter or factory worker, you will be able to show that you were exposed to PFAS chemicals.
- You were diagnosed with certain types of cancer after prolonged exposure to PFAS chemicals.
Currently, the cancers with strongest connection to PFAS exposure are:
- testicular cancer
- kidney cancer
- thyroid disease (Hypo and Hyperthyroidism; Hashimoto’s; cancer)
- ulcerative colitis
- liver cancer
- thyroid cancer
The Risk Of Cancer Is Real
Recent studies have linked the PFAS chemicals in AFFF “firefighting foam” products to a myriad to cancers.
The Centers for Disease Control and Prevention (CDC) and the American Cancer Society have classified the chemicals in AFFF firefighting foam as a possible human carcinogen.
Likewise, the International Agency for Research on Cancer (IARC) classified per- and polyfluoroalkyl substance (PFAS), as a possible human carcinogen that causes cancer.
Both the EPA and World Health Organization (WHO) have warned that exposure to PFAS may cause cancer. In fact, the EPA has classified PFAS as an “emerging contaminant”.
Other studies to watch closely are listed below:
Kidney Cancer
A recent study by Dr. Jonathan Hofmann suggests a higher kidney cancer incidence and mortality among individuals with high PFOA exposures from employment in a PFAS-producing chemical plant or residence in the surrounding community with contaminated drinking water.
Testicular Cancer
Dr. Mark Purdue is conducting a case-control study of serum PFAS levels and testicular cancer risk nested within the Department of Defense Serum Repository (DoDSR).
PFAS levels will be determined for the earliest and latest (two or more years prior to diagnosis) banked serum samples stored in DoDSR from 800 Air Force servicemen who later developed testicular cancer on active duty and 800 Air Force cancer-free controls.
Thyroid Cancer
Dr. Mark Purdue is conducting another study to investigate whether elevated pre-diagnostic serum concentrations of selected PFAS are associated with increased risks of non-Hodgkin lymphoma (NHL) and thyroid cancer.
What Can I Recover From A Washington DC AFFF Foam Lawsuit?
Every case is unique, but people who successfully file product liability lawsuits can recover money for the following damages:
- PAST AND FUTURE MEDICAL BILLS (INCLUDING MEDICATION, HOSPITAL STAYS, AND IN-HOME CARE)
- PAIN AND SUFFERING
- LOST WAGES
- LOSS OF EARNING CAPACITY
- FUNERAL EXPENSES (IN THE VENT OF A LOVED ONE’S DEATH)
- BROADLY SPEAKING, A PLAINTIFF COULD BE ENTITLED TO COMPENSATION FOR ANY PAST AND FUTURE COSTS ASSOCIATED WITH THEIR CANCER DIAGNOSIS
AFFF Lawsuit Settlement Amounts
On November 3, 2026, 3M agreed to pay $7.35 billion over nine years to resolve about 99% of current AFFF personal injury claims, which 3M puts at 115,000 to 120,000 claimants. Individual award amounts have not been published, and most payments are scheduled from 2028 through 2034. Claims against DuPont, Chemours and Corteva have not settled. The billions reported before November 2026 went to public water utilities, not to individuals. We explain the timing in When Will AFFF Lawsuit Payouts Actually Happen?
Factors That Affect Settlement Amounts
Several factors influence the value of an AFFF lawsuit settlement:
- Type and Severity of Illness: Certain cancers linked to AFFF exposure typically lead to higher settlements.
- Duration and Intensity of Exposure: Longer and more direct exposure strengthens your case.
- Evidence Strength: Medical records, exposure documentation, and expert testimony are critical.
- Economic & Non-Economic Damages: Lost wages, medical expenses, pain and suffering, and diminished quality of life are considered.
If you or a loved one has been affected by AFFF exposure in Washington DC, it is vital to seek experienced legal counsel.
The Fob & Foster Personal Injury Lawyers has extensive experience handling AFFF-related claims and can help you understand your legal options, evaluate your potential compensation, and guide you through the claims process.
How Long Do I Have To File An AFFF Lawsuit in Washington DC?
Every state is different so make sure you consult with an attorney about how long you have to file a lawsuit.
In Washington DC, you generally have two years from the date of discovery of your AFFF related injury to file a lawsuit.
Firefighting Foam (AFFF) Class Action Lawsuit Updates
Last Updated: November 6, 2026
Updates on the AFFF lawsuit will be posted in our blog throughout the litigation. We typically post an update at least once per month.
Latest Update
November 6, 2026 — 3M Agrees to Pay $7.35 Billion to Resolve AFFF Personal Injury Claims
On November 3, 3M announced an agreement to resolve about 99% of current AFFF personal injury claims, both in MDL 2873 and in other courts, for $7.35 billion paid over nine years (about $5.8 billion in present value). 3M estimates 115,000 to 120,000 claimants and does not admit liability.
- Who qualifies: claimants with kidney, testicular, liver or thyroid cancer, ulcerative colitis or thyroid disease.
- November 13 deadline: on November 4, Judge Gergel ordered lawyers to identify every eligible client they represent, filed or unfiled, by November 13, 2026. Being identified does not commit anyone to join.
- How payment works: participation is voluntary and individual award amounts have not been published. 3M pays $50 million in 2026, then installments from 2028 through 2034, and can reportedly withdraw if too few claimants join.
- Not settled: DuPont, Chemours, Corteva and BASF have not settled, and claims against them continue. Water-utility claims were resolved separately in 2023.
November 3, 2026 — 15,270 Cases Pending; Still No Personal Injury Trial Date or Settlement
The AFFF personal injury docket held essentially steady in October, with 15,270 cases pending on the JPML’s November 2 report. There is still no trial date for the personal injury cases and no settlement of individual cancer claims with 3M, DuPont, Chemours, Corteva or Tyco. Every AFFF settlement so far has been with water utilities or states.
- Incomplete claims weeded out: in September the court largely adopted a special master’s recommendations to dismiss claims that had not met the court’s information requirements, and 3M says that vetting is substantially complete.
- Next diseases: expert discovery continues on thyroid disease, ulcerative colitis and liver cancer, and the defendants’ motions to exclude the plaintiffs’ general-causation experts on thyroid disease and liver cancer are pending.
- No trial date: 3M’s October 20 quarterly report says no new bellwether trial date has been set; court-ordered mediation continues.
Editor’s note: 3M announced its personal injury settlement later on November 3; see the November 6, 2026 entry above.
September 2026 — 15,264 Cases Pending as Bellwether Discovery Grinds On With No Trial Date
The personal injury side of the AFFF litigation has settled into a slow, discovery-driven stretch. The docket barely moved in August, the second bellwether pool is working through expert discovery, and Judge Gergel has not put a personal injury trial on the calendar. The water-utility settlements are done; the individual cases are not.
- Docket size: 15,264 cases pending in MDL 2873 as of the Judicial Panel’s September 1 statistics (19,840 filed since consolidation), up just 18 from August, which tracks with the court’s pause on routine intake
- Second bellwether pool: 28 personal injury cases drawn from drinking-water exposure claims, split among kidney cancer, testicular cancer, thyroid disease, and ulcerative colitis, are in expert discovery
- Trial timing: no personal injury trial has been set since the October 2025 date was vacated; the next date is still being negotiated
- Fact-sheet dismissals: plaintiffs who did not complete the required fact sheets under CMO 37 are being dismissed, so anyone with a filed case should confirm the paperwork is current
- What has and has not settled: 3M’s $10.3 billion and the DuPont-Chemours-Corteva $1.185 billion agreements resolved public water system claims only, and no global settlement exists for individual injury claims
- What it means: with no trial date, settlement pressure comes from the bellwether workup itself; most attorneys following the docket expect a global personal injury resolution in late 2026 or 2027, and claims filed now still join that pool
August 20, 2026 – 15,246 Cases Pending as the Personal Injury Track Awaits a Trial Date
The AFFF litigation before Judge Richard Gergel in South Carolina keeps growing while the personal injury track works toward its first trial. The water-utility side of this litigation has already settled; the personal injury side has not.
- Docket size: 15,246 cases pending in MDL 2873 as of the Judicial Panel’s August 3 statistics (19,822 filed since consolidation), with new personal injury filings continuing to arrive
- Second bellwether pool: the court is developing a pool of 28 personal injury cases built from drinking-water exposure claims, split among kidney cancer, testicular cancer, thyroid disease, and ulcerative colitis, drawn from communities near Peterson Air Force Base, Colorado Springs Municipal Airport, Willow Grove Naval Air Station, and the Naval Air Warfare Center in Warminster
- Trial timing: the bellwether trial once set for October 2025 remains off the calendar, and the next personal injury trial date is still being worked out
- Settlement talks: the parties are pursuing court-supervised settlement negotiations on the personal injury side, and the court has reportedly paused routine intake of new MDL cases while those talks proceed. The Department of Defense stopped using AFFF at its installations in October 2024.
- What has and has not settled: 3M’s $10.3 billion and the DuPont-Chemours-Corteva $1.185 billion agreements resolved public water system claims only. No global settlement exists for personal injury claims, and those are the claims firefighters and military members bring
- What it means: the October 2025 first trial date was vacated and no new date has been set. With the court encouraging settlement negotiations, plaintiffs’ attorneys anticipate a global personal-injury resolution taking shape in late 2026 or 2027 — the trial calendar and those talks are the numbers to watch, not the water-utility headlines
April 4, 2026 – AFFF MDL: Where Things Stand
As of March 2026, there are approximately 15,220 personal injury claims pending in MDL 2873 in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel.
No Personal Injury Settlement Yet. No definitive settlements have been reached for personal injury claims in the MDL. As bellwether trials unfold, they will likely set the tone for broader settlement discussions. A special master continues working with plaintiff leadership and defendants on a settlement matrix to facilitate a potential global resolution.
MDL Scope Confirmed. A recent Case Management Order clarified that claims involving AFFF firefighting foam, firefighter turnout gear containing PFAS, and injuries linked to contaminated drinking water will all remain part of the MDL.
Bottom Line for Washington, D.C. Claimants. 3M’s November 2026 settlement resolves most personal injury claims against 3M, but DuPont, Chemours and Corteva have not settled, and every claimant should confirm their status and deadlines with the firm handling their claim.
January 22, 2026 – What’s Next In the AFFF Firefighter MDL
Case Volume: There are 15,213 pending cases in the MDL (down from 15,334 in December 2025); total cases (including resolved/transferred) are around 19,788.
Bellwether Trials: The first bellwether trial (focused on kidney cancer) was postponed from its original October 2025 date (vacated via Case Management Order in August 2025). No new date is confirmed, but rescheduling is expected potentially mid-2026 or later, amid ongoing expert discovery, Daubert motions, and high filings. Future bellwethers may cover other cancers (e.g., testicular, liver, thyroid).
Personal Injury Claims: These (e.g., cancers from PFAS exposure via AFFF use by firefighters/military) continue through discovery; no global settlement yet. Settlement talks persist despite trial delays.
Prior Settlements: Major deals (billions with 3M, DuPont/Chemours/Corteva, Tyco, BASF) resolved most public water system claims; administration and deadlines extend into 2025–2026.
Other Notes: AFFF litigation remains active. JPML recently denied transfers for non-AFFF PFAS claims (e.g., turnout gear or unrelated contamination), reinforcing MDL scope.
View earlier updates (2024 – 2025)
November 3, 2025 – First Bellwether Trial Delayed Due to New Filings
The first bellwether trial in the AFFF multidistrict litigation (MDL) has been delayed due to a surge in new filings. The trial, initially set to involve claims against 3M, one of the key defendants, has been postponed as the volume of new cases exceeds expectations.
While the influx of new claims is important for affected individuals to be heard, the larger-than-anticipated number of filings has temporarily impacted the litigation schedule. However, the case is still progressing, and plaintiffs can expect their day in court—unless a settlement is reached beforehand.
October 6, 2025 – Expert Deadlines Set for Thyroid and Liver Cancer Cases
In the ongoing AFFF firefighting foam litigation, Judge Gergel has updated the expert witness schedule for thyroid and liver cancer claims. Plaintiffs have already submitted their expert reports, and defendants must file theirs by October 24, 2025. Any plaintiff rebuttals are due November 21, 2025.
The Court also reaffirmed that standard expert discovery limits apply—draft reports and private expert communications remain protected. By December 12, 2025, lead counsel must meet to set a schedule for expert depositions and Daubert (expert admissibility) motions. A joint or separate proposal is due to the Court by December 19, 2025.
September 2, 2025 – Barage of AFFF Lawsuits Filed
With the September 5th deadline fast approaching, we have seen a crazy number of AFFF lawsuit filings. Roughly 40,000 new AFFF lawsuits were filed over the last 30 days. We expect thousands more lawsuits filed between now and September 5th. With so many new filings, the total number of AFFF lawsuits could top 100,000.
August 20, 2025 – Lone Pine Order Goes Into Effect September 5th
Last Friday, a CMO was entered in the AFFF MDL requiring all cases be filed by September 5th. Cases filed after September 5th will be subject to a “Lone Pine” order, which will require a host of burdensome obligations (i.e. individual expert reports, discovery, etc.). We recommend that anyone who has not filed a lawsuit do so ASAP. After September 5th, the criteria to file a lawsuit will be substantial, and many firms will stop taking new cases.
August 1, 2025 – Large Number of Unfiled AFFF Lawsuits Becomes An Issue at Medation
The parties continue to mediate in hopes to reach a global resolution. One issue that has come up in mediation is the number of unfiled AFFF cases. According to Defendants, there is a large number of unfiled lawsuits, potentially in the tens of thousands. Defendants want to know how many claims will be filed before they agree to a global settlement. Frankly, this is not unreasonable. The Court has the ability resolve this issue with a “Lone Pine” order. In the meantime, we recommend that everyone who has not already done so get their claim filed.
July 3, 2025 – Influx of AFFF Lawsuits Filed As Settlement Pressure Intensifies
At the last status conference, Judge Gergel pushed the parties to settle individual AFFF claims before the first bellwether trial starts in October 2025. At the same time, the parties have been actively negotiating settlement and working with a special master on a “settlement matrix”.
A “settlement matrix” is a system where claims are valued based on a points system. The more points a claim has, the higher the settlement value.
With settlement negotiations underway and pressure from the Court, many law firms are filing their last qualifying AFFF cases that are in inventory. For this reason, we have seen an uptick in AFFF MDL lawsuit filings as of late with the total reaching 11,096.
June 4, 2025 – Science Day Scheduled for June 20th
The main happenings in the AFFF lawsuit this month is Science Day for liver and thyroid cancer. On June 20th, Plaintiff Leadership will have the opportunity to educate Judge Gergel on the science that supports causation for liver and thyroid cancer. First impressions are important. A solid presentation at Science Day will go a long way in persuading the Court that the plaintiffs can meet their burden of proof on causation for these two diseases.
Roughly 10,500 AFFF cases have been filed into the MDL. We expect more lawsuits will be filed this year as settlement talks continue.
May 12, 2025 – Special Master Working On Developing a Settlement Matrix
Judge Gergel appointed a special master to facilitate settlement negotiations. The role of a special master is to help the parties negotiate a global settlement. Int he AFFF lawsuits, the special master is working with Plaintiff Leadership and defendants on developing and negotiating a settlement matrix (or grid) that can be used for global settlement. We remain hopeful that a global resolution will be reached by the end of the year.
April 2, 2025 – Expert Report Deadlines for Liver and Thyroid Cancer Plaintiffs
The deadlines for expert reports in cases involving liver cancer or thyroid cancer are as follows:
- July 11, 2025 – Plaintiffs’ expert reports
- August 22, 2025 – Defendants’ expert reports
We continue to see an influx of filed cases. This could be because plaintiff attorneys anticipate a global resolution in 2025, so they want to make sure they get their cases filed on the docket.
The next key date is the “Science Day” in June.
March 1, 2025 – Judge Gergel Schedules Science Day for Liver and Thyroid Cancer
Like most MDLs, the AFFF litigation initially involved a wide range of diseases. Plaintiffs have the burden of proof and the science has to support both general and specific causation. Because of this, the qualifying diseases in the AFFF lawsuits were reduced to the following:
- testicular cancer
- kidney cancer
- thyroid disease (Hypo and Hyperthyroidism; Hashimoto’s)
- ulcerative colitis
However, many plaintiff attorneys and their experts have been arguing that the science is sufficiently strong enough to support claims for liver and thyroid cancer. Judge Gergel apparently believes its worth the Court’s time to schedule a “science day” on June 6, 2025.
At the science day, the parties will educate the Court on the the science connecting AFFF exposure to liver and thyroid cancer. If the science day goes well, the Judge Gergel may expand the MDL to include these two cancers. Overall, we believe the science day is a positive step.
Febuary 10, 2025 – Parties Request Discovery Track for Ulcerative Colitis Cases
The parties in the AFFF lawsuits are requesting a new case management order to provide a framework for discovery and bellwether cases for ulcerative colitis cases. The science connecting AFFF exposure to ulcerative colitis is very strong. Ulcerative colitis is also one of the more common diseases in the MDL. As a result, it makes sense to have case specific discovery and a bellwether trial selection process specifically for ulcerative colitis claimants.
January 4, 2025 – Will the AFFF Lawsuit Settle in 2025?
We blogged last month that the first Tier 2 AFFF bellwether trial is scheduled for October 6, 2025. In light of this, we believe there is a decent chance that qualifying AFFF lawsuits may settle by the end of 2025.
Bellwether trials are crucial in a MDL because they put pressure on both sides to settle. From plaintiffs perspective, the risk of going to trial is that the jury returning a defense verdict. And from defendants’ point of view, the risk is the jury awarding a nuclear verdict to the plaintiff.
As pressure mounts before the bellwether trial in October, we are hopeful that the parties are able to reach a global settlement.
December 14, 2024 – First Tier 2 Bellwether Trial Scheduled In October 2025
The MDL Court scheduled the first Tier 2 Group A bellwether trial in the AFFF litigation (MDL) for October 6, 2025.
Tier 2 diseases in the AFFF lawsuit include kidney and testicular cancer. The Tier 2 discovery track cases are divided into Group A or B.
December 2, 2024- Drop in the Number of Filed AFFF Lawsuits
The number filed lawsuits in the AFFF MDL is now around 7400 cases. At one point there were roughly 9000 pending cases. However, cases that were part of a prior global settlement have been dismissed. This in turn has reduced the number of cases on the Court’s docket .
November 1, 2024 – Judge Gergel Enters New Case Management Order on PPFs
In mass tort litigation, plaintiffs produce Plaintiff Profile Forms (PPFs) to the defendants. PPFs are also called Plaintiff Fact Sheets. The information contained in the PPFs provides key facts and evidence supporting a plaintiff’s case.
Increasingly, PPFs are more difficult and time consuming to complete. As a result, many plaintiffs submit incomplete PPFs. If this happens, the defendants will initiate protocols set by the court that could eventually lead to the dismissal of deficient cases.
Judge Gergel entered Case Management Order No. 31 (CMO 31), which sets forth new requirement and timelines for PPFs. We encourage every plaintiff to follow up with your attorney to make sure your PPF complies with CMO 31.
October 1, 2024 – Slow Couple of Weeks in the AFFF MDL
There is not much to report from the last several weeks. Now that the Court has selected the first seven bellwether cases, we expect the next battle in the litigation will consist of Daubert motions. Plaintiffs have the burden to prove that the chemicals in the foam caused his or her injuries. To prove causation, plaintiffs typically rely on expert testimony. Experts often include medical doctors and scientists.
A Daubert motion is where the defense will attack Plaintiff’s experts and try to exclude their testimony from trial. If plaintiffs’ experts are excluded, then plaintiffs will lack the scientific basis needed to prove causation. We expect the expert battles will take place over the next 9-12 months.
September 2, 2024 – New Study by University of Arizona Links AFFF Usage to Water Contamination
Researchers from the University of Arizona released a study linking PFAS chemicals found in a small Washington town’s water supply to AFFF foam used at the nearby Fairchild Air Force Base (AFB). This study reflects how AFFF chemicals can impact non-users such as nearby residents. At this time, lawsuits involving AFFF foam are limited to the firefighters and other personal who were directly exposed. Time will tell if the scope of lawsuits broaden.
August 2, 2024 – Judge Selects 7 Bellwether Cases
Judge Gergel who presides over the MDL in the District of South Carolina has selected seven cases that will serve as the initial “bellwether cases”. A bellwether trial is like a test trial that allows the parties to gauge the strength and weaknesses of the case through expert discovery and a jury trial. This is a big deal because typically global resolutions are not reached until bellwether trials happen. The seven bellwether plaintiffs are all Pennsylvania residents who were diagnosed with at least one of the following diseases:
- kidney cancer
- testicular cancer
- thyroid disease
- ulcerative colitis
July 15, 2024 – Air Force Removes AFFF/PFAS Chemical from its Stock
The Air Force announced it is replacing current stocks of AFFF in fire and emergency services vehicles with a fluorine-free formulation. The new formulatoin does not contain chemicals with tox effects. This move is part of a larger Defense Department-wide effort to remove PFAS from firefighting activities. We applaud the removal of any AFFF based products used by firefighters.
July 1, 2024 – Landfills Linked to PFAS Chemicals
A new study by researchers at the University of Florida found that landfills release various types of “forever chemicals” [PFAS]. It appears these chemicals pollute the air as products in the landfill break down. Time will tell if a new category of air pollution lawsuits will result from PFAS released by landfills.
June 2, 2024 – Pathway for Non-Qualifying Diseases
In the current MDL, the types of diseases that will be litigated has been narrowed. This usually happens in a MDL. So what happens to all of the filed cases that do not have a “qualifying disease”? The Court established a pathway for cases that do not qualify for the MDL to continue. Specifically, the Court annouced a process where the non-qualifying cases can be voluntary dismissed and the statute of limitations tolled while the litigation plays out. These cases can be refiled at a later date.
May 1, 2024 – Number of Cases reaches 8,000
On a consistent basis, several hundred cases are filed each month in the MDL. With 323 cases filed in April, the total number of cases crosses the 8,000 mark.
April 1, 2024 – The Court Is Gearing Up for a “Science Day”
The Court entered Case Management Order 28 [CMO-28] which sets forth the obligations of the parties leading up to a “Science Day”.
A Science Day is a proceeding where the parties present an overview of the scientific evidence and expert testimony in connection with various diseases to the Court. In other words, a science day is a chance to educate the Judge on medical causation and other important issues.
CMO-28 requires the parties to exhchange peer reviewed studies which support or dispute as association of AFFF with the list of diseases identified by the PEC.
By May 15, 2024, the parties must submit the peer reviewed studies to the Court. Thereafter, the Court will schedule a science day.
The order also requires the parties to meet and confer on the process for selecting bellwether cases (test trials) and regarding Daubert and dispositive motions.
February 10, 2024 – Washington D.C. Resident Files AFFF Lawsuit
A former firefighter and resident of Washington D.C. filed a lawsuit against the makers of AFFF alleging the PFAS chemicals caused his testicular cancer. The case will be transferred to the MDL Court overseeing the AFFF litigation. If the case is not resolved through the MDL, the case may get transferred back to federal court in D.C.
AFFF Claims in Other States
See our main Alabama AFFF lawsuit guide, or our guides for Georgia and Tennessee exposure.
We Are Not Accepting AFFF Cases
Fob & Foster Personal Injury Lawyers are not accepting new AFFF firefighting foam or PFAS personal injury claims. Following 3M’s November 3, 2026 settlement, the remaining claims are being handled through the MDL’s settlement process and by firms with existing AFFF dockets. If you were exposed to AFFF and have been diagnosed with a PFAS-linked condition, please speak with a firm that is handling these claims soon; filing and identification deadlines run regardless of who represents you. If you have a different injury claim in Alabama, Georgia, or Tennessee, call (205) 407-6009 or see the cases we do handle on our practice areas page.
